Aug 2026 $77 M Private placement after listing $50 to $250 million 44
Ensysce Biosciences, Inc.: Private sale, Aug 2026 × Investors in this round 44 investors had bought by the notice of Aug 20, 2026: 44 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $77 M of $77 M offered
Smallest investment taken no minimum stated
What was sold equity, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $1,289,946
Finders' fees $200,000
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice D Lynn Kirkpatrick · Executive Officer, Director David Lynn Humphrey · Executive Officer James Lynn Morrison · Executive Officer, Director Adam Lynn Levin · Director Bob Lynn Gower · Director Steve Lynn Martin · Director William Lynn Chang · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round UBS Securities LLC (CRD 000007654) · New York, New York Sold in all US states, and outside the US Cantor Fitzgerald & Co. (CRD 000000134) · New York, New York Sold in all US states, and outside the US Remarks in the notice On the amounts: “Of Total Amount Sold, $38.6 million is subject to certain contingencies”Signed by Dr. Lynn Kirkpatrick, Ceo. Newest notice filed Aug 20, 2026. Read the notice at the SEC .
equity SEC Apr 2025 $2 M Private placement after listing $2 to $10 million 8
Ensysce Biosciences, Inc.: Private sale, Apr 2025 × Investors in this round 8 investors had bought by the notice of Apr 25, 2025: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $154,001
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice D Lynn Kirkpatrick · Executive Officer, Director David Lynn Humphrey · Executive Officer Adam Lynn Levin · Director Andrew Lynn Benton · Director Bob Lynn Gower · Director Curtis Lynn Rosebraugh · Director Lee Lynn Rauch · Director Steve Lynn Martin · Director William Lynn Chang · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round H.C. Wainwright & Co., LLC (CRD 000000375) · New York, New York Sold in NY Remarks in the notice On fees: “Consists of cash compensation for a separate warrant inducement and issuance of warrants to purchase 44,126 shares of common stock.”Signed by Dr. Lynn Kirkpatrick, President and CEO. Newest notice filed Apr 25, 2025. Read the notice at the SEC .
options SEC Mar 2025 $1 M Private placement after listing Under $2 million 8
Ensysce Biosciences, Inc.: Private sale, Mar 2025 × Investors in this round 8 investors had bought by the notice of Apr 14, 2025: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $142,950
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice D Lynn Kirkpatrick · Executive Officer, Director David Lynn Humphrey · Executive Officer Adam Lynn Levin · Director Andrew Lynn Benton · Director Bob Lynn Gower · Director Curtis Lynn Rosebraugh · Director Lee Lynn Rauch · Director Steve Lynn Martin · Director William Lynn Chang · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round H.C. Wainwright & Co., LLC (CRD 000000375) · New York, New York Sold in NY Remarks in the notice On fees: “Consists of amounts received in a concurrent registered offering of $77,000 (commission), $50,000 (expense), $15,950 (clearing fee) and warrants to purchase 22,063 shares of common stock.”Signed by Dr. Lynn Kirkpatrick, President and CEO. Newest notice filed Apr 14, 2025. Read the notice at the SEC .
options SEC Aug 2024 $5 M Private placement after listing $2 to $10 million 4
Ensysce Biosciences, Inc.: Private sale, Aug 2024 × Investors in this round 4 investors had bought by the notice of Sep 12, 2024: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $454,845
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice D Lynn Kirkpatrick · Executive Officer, Director David Lynn Humphrey · Executive Officer Adam Lynn Levin · Director Andrew Lynn Benton · Director Bob Lynn Gower · Director Curtis Lynn Rosebraugh · Director Lee Lynn Rauch · Director Steve Lynn Martin · Director William Lynn Chang · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round H.C. Wainwright & Co., LLC (CRD 000000375) · New York, New York Sold in NY Remarks in the notice On fees: “Includes commissions & fees received in a concurrent registered offering of $353,895, $35,000 (non-accountable expense), $50,000 (legal), $15,950 (clearing fees) and warrants to purchase 752,969 shares of common stock.”On the amounts: “Includes totals from 3 public and non-public offerings simultaneously closed; specific consideration was not delineated for the non-public offerings, which involved warrants for up to 29,469,869 shares of common stock.”Signed by Dr. Lynn Kirkpatrick, President and CEO. Newest notice filed Sep 12, 2024. Read the notice at the SEC .
options SEC Feb 2024 $5 M Private placement after listing $2 to $10 million 4
Ensysce Biosciences, Inc.: Private sale, Feb 2024 × Investors in this round 4 investors had bought by the notice of Feb 21, 2024: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $265,950
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice D Lynn Kirkpatrick · Executive Officer, Director David Lynn Humphrey · Executive Officer Adam Lynn Levin · Director Andrew Lynn Benton · Director Bob Lynn Gower · Director Curtis Lynn Rosebraugh · Director Lee Lynn Rauch · Director Steve Lynn Martin · Director William Lynn Chang · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round H.C. Wainwright & Co., LLC (CRD 375) · New York, New York Sold in NY Remarks in the notice On fees: “(i) $200,000 cash fee, (ii) $20,000 for non-accountable expenses, (iii) $30,000 for legal expenses, (iv) $15,950 for clearing fees and (v) warrants to purchase 252,123 shares (7% of the shares placed) at an exercise price of $1.6375 per share”On the amounts: “(i) warrants to purchase 7,203,504 shares of common stock issued in return of exercise of outstanding warrants to purchase 3,601,752 shares of common stock and (ii) warrants to the placement agent for 252,123 shares”Signed by Dr. Lynn Kirkpatrick, President and CEO. Newest notice filed Feb 21, 2024. Read the notice at the SEC .
options SEC Feb 2023 $3 M Private placement after listing $2 to $10 million 8
Ensysce Biosciences, Inc.: Private sale, Feb 2023 × Investors in this round 8 investors had bought by the notice of Mar 1, 2023: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $210,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice D Lynn Kirkpatrick · Executive Officer, Director David Lynn Humphrey · Executive Officer Adam Lynn Levin · Director Andrew Lynn Benton · Director Bob Lynn Gower · Director Curtis Lynn Rosebraugh · Director Lee Lynn Rauch · Director Steve Lynn Martin · Director William Lynn Chang · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round H.C. Wainwright & Co., LLC (CRD 375) · New York, New York Sold in all US states Remarks in the notice On the amounts: “Warrants to purchase common stock to investors for up to 3,571,431 shares at $0.715/share and to designees of H.C. Wainwright & Co., LLC for up to 250,000 shares at $1.05/share in connection with a 2/2/2023 registered direct offering.”Signed by Dr. Lynn Kirkpatrick, President and CEO. Newest notice filed Mar 1, 2023. Read the notice at the SEC .
options SEC Jun 2022 $4 M Private placement after listing $2 to $10 million 3
Ensysce Biosciences, Inc.: Private sale, Jun 2022 × Investors in this round 3 investors had bought by the notice of Jul 8, 2022: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $8 M offered; $4 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees $200,000
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice D Lynn Kirkpatrick · Executive Officer, Director David Lynn Humphrey · Executive Officer Adam Lynn Levin · Director Andrew Lynn Benton · Director Bob Lynn Gower · Director Curtis Lynn Rosebraugh · Director Lee Lynn Rauch · Director Steve Lynn Martin · Director William Lynn Chang · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Lake Street Capital Markets, LLC (CRD 164447) · broker-dealer Lake Street Capital Markets, LLC (CRD 164447) · Minneapolis, Minnesota Sold in NY Remarks in the notice On the amounts: “Amounts include an original issue discount in the amount of six percent (6%).”Signed by Dr. Lynn Kirkpatrick, President and CEO. Newest notice filed Jul 8, 2022. Read the notice at the SEC .
debt, options SEC Sep 2021 $5 M Private placement after listing $2 to $10 million 3
Ensysce Biosciences, Inc.: Private sale, Sep 2021 × Investors in this round 3 investors had bought by the notice of Oct 6, 2021: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $16 M offered; $11 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees $250,000
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice D Lynn Kirkpatrick · Executive Officer, Director David Lynn Humphrey · Executive Officer Adam Lynn Levin · Director Andrew Lynn Benton · Director Bob Lynn Gower · Director Curtis Lynn Rosebraugh · Director Steve Lynn Martin · Director William Lynn Chang · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Lake Street Capital Markets, LLC (CRD 164447) · broker-dealer Lake Street Capital Markets, LLC (CRD 164447) · Minneapolis, Minnesota Sold in NY Remarks in the notice On the amounts: “Amounts include an original issue discount in the amount of six percent (6%).”Signed by Dr. Lynn Kirkpatrick, President and CEO. Newest notice filed Oct 6, 2021. Read the notice at the SEC .
debt, options SEC